These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576 [TBL] [Abstract][Full Text] [Related]
4. Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection. Huang J; Al-Mozaini M; Rogich J; Carrington MF; Seiss K; Pereyra F; Lichterfeld M; Yu XG Retrovirology; 2012 Jan; 9():11. PubMed ID: 22289474 [TBL] [Abstract][Full Text] [Related]
6. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j. Morel E; Bellón T J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926 [TBL] [Abstract][Full Text] [Related]
7. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. Bashirova AA; Martin-Gayo E; Jones DC; Qi Y; Apps R; Gao X; Burke PS; Taylor CJ; Rogich J; Wolinsky S; Bream JH; Duggal P; Hussain S; Martinson J; Weintrob A; Kirk GD; Fellay J; Buchbinder SP; Goedert JJ; Deeks SG; Pereyra F; Trowsdale J; Lichterfeld M; Telenti A; Walker BD; Allen RL; Carrington M; Yu XG PLoS Genet; 2014 Mar; 10(3):e1004196. PubMed ID: 24603468 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715 [TBL] [Abstract][Full Text] [Related]
9. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. Allan DS; Lepin EJ; Braud VM; O'Callaghan CA; McMichael AJ J Immunol Methods; 2002 Oct; 268(1):43-50. PubMed ID: 12213342 [TBL] [Abstract][Full Text] [Related]
10. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Apps R; Gardner L; Sharkey AM; Holmes N; Moffett A Eur J Immunol; 2007 Jul; 37(7):1924-37. PubMed ID: 17549736 [TBL] [Abstract][Full Text] [Related]
11. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway. Liang S; Ristich V; Arase H; Dausset J; Carosella ED; Horuzsko A Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8357-62. PubMed ID: 18550825 [TBL] [Abstract][Full Text] [Related]
12. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. HoWangYin KY; Loustau M; Wu J; Alegre E; Daouya M; Caumartin J; Sousa S; Horuzsko A; Carosella ED; LeMaoult J Cell Mol Life Sci; 2012 Dec; 69(23):4041-9. PubMed ID: 22802125 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer. Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044 [TBL] [Abstract][Full Text] [Related]
14. Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs. Alaoui L; Palomino G; Zurawski S; Zurawski G; Coindre S; Dereuddre-Bosquet N; Lecuroux C; Goujard C; Vaslin B; Bourgeois C; Roques P; Le Grand R; Lambotte O; Favier B Cell Mol Life Sci; 2018 May; 75(10):1871-1887. PubMed ID: 29134249 [TBL] [Abstract][Full Text] [Related]
15. Tolerization of dendritic cells by HLA-G. Ristich V; Liang S; Zhang W; Wu J; Horuzsko A Eur J Immunol; 2005 Apr; 35(4):1133-42. PubMed ID: 15770701 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110 [TBL] [Abstract][Full Text] [Related]
17. Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance. Wu J; Zhang W; Hernandez-Lopez P; Fabelo E; Parikh M; Mulloy LL; Horuzsko A Hum Immunol; 2009 Dec; 70(12):988-94. PubMed ID: 19664670 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Lepin EJ; Bastin JM; Allan DS; Roncador G; Braud VM; Mason DY; van der Merwe PA; McMichael AJ; Bell JI; Powis SH; O'Callaghan CA Eur J Immunol; 2000 Dec; 30(12):3552-61. PubMed ID: 11169396 [TBL] [Abstract][Full Text] [Related]
19. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. Gonen-Gross T; Achdout H; Gazit R; Hanna J; Mizrahi S; Markel G; Goldman-Wohl D; Yagel S; Horejsí V; Levy O; Baniyash M; Mandelboim O J Immunol; 2003 Aug; 171(3):1343-51. PubMed ID: 12874224 [TBL] [Abstract][Full Text] [Related]
20. HLA-G modulates immune responses by diverse receptor interactions. Hofmeister V; Weiss EH Semin Cancer Biol; 2003 Oct; 13(5):317-23. PubMed ID: 14708711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]